Menu
2025 Session

Budget Amendments - HB1600 (Conference Report)

View Budget Item
View Budget Item amendments

Analysis of Implementing a Medicaid Single Pharmacy Manager

Item 292 #5c

Item 292 #5c

First Year - FY2025 Second Year - FY2026
Health and Human Resources
Department of Medical Assistance Services FY2025 $500,000 FY2026 $0 GF
FY2025 $500,000 FY2026 $0 NGF

Language
Page 395, line 2, strike "$322,845,151" and insert "$323,845,151".

Page 402, after line 29, insert:

"MM.1. Out of this appropriations, $500,000 from the general fund and $500,000 from nongeneral funds the first year shall be provided to the Department of Medical Assistance Services (DMAS) to conduct a comprehensive evaluation of the potential benefits, cost savings, and implementation considerations associated with utilizing a single third-party administrator to serve as the pharmacy benefit manager (PBM) for all Medicaid pharmacy benefits. This evaluation shall include an analysis of financial efficiencies, improved transparency, and the impact on patient access to pharmacy services, including community critical access pharmacies, along with timelines and cost for both implementation and ongoing operation and maintenance.  As part of this process, DMAS shall engage an independent consultant with direct experience: (i) advising Medicaid fraud control units; and (ii) working with states that have transitioned to a single PBM model, to assess best practices and provide guidance on structuring a model that maximizes cost savings and operational effectiveness. The consultant shall not be currently engaged by any managed care organization or by any PBM contracted with a managed care organization.

2. The evaluation shall also include a detailed assessment of the implementation costs associated with transitioning to a single PBM model. Any such implementation costs shall be analyzed in comparison to the projected cost savings identified in the independent evaluation to ensure fiscal accountability. Additionally, the evaluation shall include a review of fee-for-service and managed care pharmacy dispensing fees and provide recommendations for adjustments necessary to maintain adequate pharmacy participation and patient access. DMAS shall report its findings, including projected implementation and ongoing costs, anticipated cost savings, recommended pharmacy dispensing fees, timeline for implementation, and any other recommendations for improving the administration of Medicaid pharmacy benefits, to the Governor and the General Assembly by December 1, 2025.  Any unexpended balances for the purposes specified in paragraph MM.1. and MM.2. which are unexpended on June 30, 2025, shall not revert to the general fund but shall be carried forward and reappropriated in fiscal year 2026."



Explanation

(This amendment provides $500,000 from the general fund and $500,000 from nongeneral funds the first year and language directing the Department of Medical Assistance Services to engage an independent consultant to conduct a comprehensive analysis of the costs and benefits and other considerations associated with the implementation of a single third-party administrator to serve as the pharmacy benefit manager for all Medicaid pharmacy benefits. Language provides authority to carryover funding for the analysis from fiscal year 2025 to fiscal year 2026 in the event the funds are not expended in the first year.)